157 related articles for article (PubMed ID: 2110815)
21. Mechanism of oncogenicity for bioreductive drugs.
Hei TK; Piao CQ; He ZY; Hall EJ
Int J Radiat Oncol Biol Phys; 1992; 22(4):747-50. PubMed ID: 1544847
[TBL] [Abstract][Full Text] [Related]
22. Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
Austen KR; Jenner TJ; O'Neill P; Fielden EM
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):281-8. PubMed ID: 3497125
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of hypoxic and aerobic cytotoxicity of mitomycin C in Chinese hamster V79 cells.
Krishna MC; DeGraff W; Tamura S; Gonzalez FJ; Samuni A; Russo A; Mitchell JB
Cancer Res; 1991 Dec; 51(24):6622-8. PubMed ID: 1660344
[TBL] [Abstract][Full Text] [Related]
24. Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU 1069.
Walling J; Stratford IJ; Adams GE; Stephens MA
Int J Radiat Biol Relat Stud Phys Chem Med; 1988 Apr; 53(4):641-9. PubMed ID: 3258298
[TBL] [Abstract][Full Text] [Related]
25. Oxygen and exposure kinetics as factors influencing the cytotoxicity of porfiromycin, a mitomycin C analogue, in Chinese hamster ovary cells.
Marshall RS; Rauth AM
Cancer Res; 1988 Oct; 48(20):5655-9. PubMed ID: 3167822
[TBL] [Abstract][Full Text] [Related]
26. Radiosensitizing and cytotoxic effects of nitroimidazoles in CHO cells expressing elevated levels of glutathione-S-transferase.
Stratford IJ; Hickson ID; Robson CN; Stephens M
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1307-10. PubMed ID: 2523884
[TBL] [Abstract][Full Text] [Related]
27. NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line.
Saunders MP; Patterson AV; Chinje EC; Harris AL; Stratford IJ
Br J Cancer; 2000 Feb; 82(3):651-6. PubMed ID: 10682679
[TBL] [Abstract][Full Text] [Related]
28. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
Hill RP; Gulyas S; Whitmore GF
Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
[TBL] [Abstract][Full Text] [Related]
29. The effect of pH on the aerobic and hypoxic cytotoxicity of SR4233 in HT-29 cells.
Skarsgard LD; Skwarchuk MW; Vinczan A; Chaplin DJ
Br J Cancer; 1993 Oct; 68(4):681-3. PubMed ID: 8398693
[TBL] [Abstract][Full Text] [Related]
30. DNA damaging effects and voltammetric studies on the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4-dioxide, SR4233, as a function of pH.
Tocher JH; Virk NS; Edwards DI
Biochem Pharmacol; 1990 Sep; 40(6):1405-10. PubMed ID: 2144963
[TBL] [Abstract][Full Text] [Related]
31. The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
Stratford IJ; Walling JM; Silver AR
Br J Cancer; 1986 Mar; 53(3):339-44. PubMed ID: 3754453
[TBL] [Abstract][Full Text] [Related]
32. Bioreductive therapies: an overview of drugs and their mechanisms of action.
Rauth AM; Melo T; Misra V
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):755-62. PubMed ID: 9845091
[TBL] [Abstract][Full Text] [Related]
33. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
Jenner TJ; O'Neill P; Crump PW; Fielden EM; Sapora O; Santodonato L
Biochem Pharmacol; 1991 Oct; 42(9):1705-10. PubMed ID: 1930296
[TBL] [Abstract][Full Text] [Related]
34. Effect of radiation and tirapazamine (SR-4233) on three melanoma cell lines.
Zhang M; Stevens G
Melanoma Res; 1998 Dec; 8(6):510-5. PubMed ID: 9918413
[TBL] [Abstract][Full Text] [Related]
35. Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions.
Marshall RS; Paterson MC; Rauth AM
Br J Cancer; 1989 Mar; 59(3):341-6. PubMed ID: 2467684
[TBL] [Abstract][Full Text] [Related]
36. Bioreductive drugs: from concept to clinic.
McKeown SR; Cowen RL; Williams KJ
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):427-42. PubMed ID: 17482438
[TBL] [Abstract][Full Text] [Related]
37. The influence of hypoxia on the cytotoxicity of concomitant KW-2149 and ionizing irradiation in Chinese hamster fibroblasts.
Egelmeers A; Dirix LY; Lyczek J; De Bruijn EA; Van Oosterom AT; Scalliet P
Anticancer Drugs; 1996 Jul; 7(5):586-90. PubMed ID: 8862727
[TBL] [Abstract][Full Text] [Related]
38. Hypoxic cells as specific drug targets for chemotherapy.
Kennedy KA
Anticancer Drug Des; 1987 Oct; 2(2):181-94. PubMed ID: 3130070
[TBL] [Abstract][Full Text] [Related]
39. [In vitro oxygen-dependent survival of 2 human cell lines after radiation combined with tirapazamine (SR-4233) and cisplatin].
Lartigau E; Stern S; Guichard M
Cancer Radiother; 2000; 4(3):217-22. PubMed ID: 10897765
[TBL] [Abstract][Full Text] [Related]
40. Bioreduction of RSU 1069 and mitomycin C after dearterialization.
Wang LQ; Persson BG; Bengmark S
Eur J Surg Oncol; 1993 Oct; 19(5):455-62. PubMed ID: 8405482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]